Conference Coverage
Conference Coverage
Gene, risk signatures could predict PARP inhibitor response in breast cancer
SAN ANTONIO – PARPi 7, BRCAness, and MammaPrint high1/(ultra)high2 signatures could help predict response to combination therapy with the PARP...
Conference Coverage
SLND after neoadjuvant chemo is feasible, but more study needed
SAN ANTONIO – Sentinel lymph node detection after neoadjuvant chemotherapy (NAC) is a safe and feasible strategy for preventing unnecessary...
Conference Coverage
VIDEO: Watson helps oncologists sleuth out best options in breast cancer
SAN ANTONIO – Every day, practicing oncologists sort through mountains of data to make the best possible therapeutic decisions for their patients...
Conference Coverage
PIK3 inhibitor gives slight PFS edge at high cost for HR+/HER2– advanced breast cancer
SAN ANTONIO – A combination of a PI3K inhibitor and selective estrogen receptor down-regulator (SERD) met its primary endpoint of 2.1 months...
Conference Coverage
Cooling device reduces breast cancer–related alopecia during chemotherapy
SAN ANTONIO – About half of the women with stage 1 or 2 breast cancer who were treated using a scalp cooling device during chemotherapy retained...
Conference Coverage
VIDEO: AIs associated with endothelial dysfunction, a predictor of CVD
SAN ANTONIO – Aromatase inhibitors (AIs) appear to be associated with declines in vascular endothelial function, which in turn have been...
Conference Coverage
It’s elementary: Watson aids in breast cancer decisions
SAN ANTONIO – In this case, Watson is an artificial intelligence platform being developed in the United States and used in clinical practice in...
Conference Coverage
VIDEO: Watson for Oncology offers electronic curbside consults in breast cancer
Andrew Norden, MD, describes how Watson for Oncology works, and how different versions of the Watson platform are being used in medicine...
Conference Coverage
VIDEO: Abemaciclib reduces Ki67 expression in early HR+/HER2– breast cancer
SAN ANTONIO – Abemaciclib, both alone and in combination with anastrozole, significantly reduced Ki67 expression vs. anastrozole monotherapy after...
Conference Coverage
Aromatase inhibitor effect on endothelial function may lead to CVD
Aromatase inhibitors appear to have a decremental effect on vascular endothelial function, which could contribute to cardiovascular disease.